Ormstad K, Moldéus P
Chemioterapia. 1985 Oct;4(5):343-8.
Several xenobiotics undergo biotransformation reactions which yield reactive and potentially toxic compounds. Activation may occur via cytochrome P-450-mediated oxidation, prostaglandin synthetase-related hydroperoxidase-activity, or alcohol dehydrogenase/aldehyde dehydrogenase activity. The reactive metabolites thus formed may initiate lipid peroxidation or covalent binding to cell macromolecules, and secondarily lead to acute cytotoxicity or to tumorigenesis. Most cells possess mechanisms for protection against chemical toxicity, e.g. glutathione-related pathways and epoxide hydrolase activity. A possible strategy in handling toxic drug effects in the clinical situation may be chemotherapeutic manipulations aiming at a stimulation of protective mechanisms or at an inhibition of activating pathways.
几种外源性物质会经历生物转化反应,产生具有反应活性且可能有毒的化合物。活化可能通过细胞色素P-450介导的氧化、前列腺素合成酶相关的氢过氧化物酶活性或乙醇脱氢酶/乙醛脱氢酶活性发生。由此形成的反应性代谢产物可能引发脂质过氧化或与细胞大分子的共价结合,继而导致急性细胞毒性或肿瘤发生。大多数细胞具有抵御化学毒性的机制,例如谷胱甘肽相关途径和环氧化物水解酶活性。在临床情况下处理有毒药物效应的一种可能策略可能是进行化疗操作,旨在刺激保护机制或抑制活化途径。